Ergometrine
Ergometrine, also known as ergonovine and sold under the brand names Ergotrate, Ergostat, and Syntometrine among others, is a medication used to cause contractions of the uterus to treat heavy vaginal bleeding after childbirth. It can be used either by mouth, by injection into a muscle, or injection into a vein. It begins working within 15 minutes when taken by mouth and is faster in onset when used by injection. Effects last between 45 and 180 minutes.
Clinical data | |
---|---|
Trade names | Ergometrine Maleate, Ergonovine Maleate, Ergotrate, Ergotrate Maleate, Ergostat, Syntometrine, others |
Other names | ergonovine; d-lysergic acid β-propanolamide; d-lysergic acid α-hydroxymethylethylamide |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Liver (partly CYP3A4) |
Elimination half-life | 2-phase (10 min; 2 hrs) |
Excretion | Biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.441 |
Chemical and physical data | |
Formula | C19H23N3O2 |
Molar mass | 325.412 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
| |
(verify) |
Common side effect include high blood pressure, vomiting, seizures, headache, and low blood pressure. Other serious side effects include ergotism. It was originally made from the rye ergot fungus but can also be made from lysergic acid. Ergometrine is regulated because it can be used to make lysergic acid diethylamide (LSD).
Ergometrine was discovered in 1932. It is on the World Health Organization's List of Essential Medicines.